Dupixent 300 MG/2 ML syringe 2ML

Ended Awarded

Contract number
SPE2DB25FAUAB
Awardee
Awarding agency
Obligated
$35,586

Award facts

Contract value 100% obligated
$35,586.09 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

This contract award is for the pharmaceutical product Dupixent 300 mg/2 ml syringe 2 ml, awarded by the Defense Logistics Agency (DLA) to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business. The $35,586.09 firm fixed-price delivery order contract has a completion date of November 13, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a wide range of pharmaceutical products to support the medical supply needs of military health facilities. This award is not associated with any set-aside designations.

Quick answers

Who was awarded contract SPE2DB25FAUAB?

SPE2DB25FAUAB was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 12, 2024.

How much is contract SPE2DB25FAUAB worth?

The government has obligated $35,586 on SPE2DB25FAUAB.

Is contract SPE2DB25FAUAB an order under another contract?

Yes. SPE2DB25FAUAB is a delivery order under SPE2DB24D2106, an indefinite delivery contract.

Was contract SPE2DB25FAUAB competed?

The extent of competition for SPE2DB25FAUAB was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award